DRP008561
16S rRNA gene V1-V2 amplicon sequencing of patients with esophageal cancer
To clarify the relationship between the effects and adverse events of cancer chemotherapy and gut microbiota, fecal samples of 73 patients with esophageal cancer scheduled to undergo neoadjuvant chemotherapy were sampled and analyzed by 16S rRNA gene amplicon sequencing.
To clarify the relationship between the effects and adverse events of cancer chemotherapy and gut microbiota, fecal samples of 73 patients with esophageal cancer scheduled to undergo neoadjuvant chemotherapy were sampled and analyzed by 16S rRNA gene amplicon sequencing.